Join
Live feed
·
PRReleasevia Quantisnow
Poseida Therapeutics Inc. logo

Poseida Therapeutics Presents Preliminary Results from Phase 1 Trial of P-PSMA-101 at the 6th Annual CAR-TCR Summit

ByQuantisnow·Wall Street's wire, on your screen.
PSTX· Poseida Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PSTX (Poseida Therapeutics Inc.) and more on Quantisnow.